A systematic review of the efficacy and safety of second generation antipsychotics in the treatment of mania - 01/01/05
, C. Thompson a, I. Bitter b, cBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 9 |
| Iconographies | 0 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Second generation antipsychotic agents are increasingly used in the management of acute mania. A systematic review of the efficacy and safety of these agents, as both monotherapy and in combination with mood stabilisers, was performed to establish the evidence for their use. Randomised controlled trials (RCTs) were critically appraised in more detail than studies that presented lower levels of evidence such as case reports, case series and open label follow up studies. We found 11 RCTs reporting on patients treated with second generation antipsychotics for acute bipolar mania, of which three included randomisation between the second generation antipsychotic and placebo, and eight between a mood stabiliser combined with either the second generation antipsychotic or placebo. Data from non-randomised trials is also presented.
Le texte complet de cet article est disponible en PDF.Keywords : Mania, Bipolar disorder, Second generation, Antipsychotic, Efficacy, Safety
Plan
Vol 21 - N° 1
P. 1-9 - janvier 2006 Retour au numéro
Article précédent
- Editorial Board
- Meta-analysis of drop-out rates in randomised clinical trials, comparing typical and atypical antipsychotics in the treatment of schizophrenia
- José Luis R. Martin, Víctor Pérez, Montse Sacristán, Fernando Rodríguez-Artalejo, Cristóbal Martínez, Enric Álvarez
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?